Trends in Metabolic and Bariatric Surgery Use During the GLP-1 Receptor Agonist Era

Authors:

Abstract
This cross-sectional analysis examines trends through 2025 in the use of metabolic and bariatric surgery during a period of increasing use of glucagon-like peptide-1 (GLP-1) receptor agonists.